News 2023-08-29
Pharma Digital Intelligence Summit will be held on 5th, September, 2023
- Background
In order to thoroughly implement General Secretary Xi Jinping’s important exposition on the development of digital economy, his spirit of sending congratulatory letters to the Smart China Expo three times, his vital instruction of “Continue to host high-standard Smart China Expo and deeply participate in international cooperation in the digital economy”, as well as the direction of actively promote the development of the digital economy, firmly implement big data intelligent innovation, and focus on "internationalization, specialization and marketization“, Chongqing Municipal Government will continue to join hands with Ministry of Industry and Information Technology, National Development and Reform Commission, Ministry of Science and Technology, Cyberspace Administration of China, Chinese Academy of Sciences, Chinese Academy of Engineering, China Association for Science and Technology, and Ministry of Trade & Industry Singapore, and host 2023 Smart China Expo together.
The Pharma Digital Intelligence Summit (PHDI 2023)is an important summit under Smart China Expo. This summit will closely align with the theme of “Cohesion on Digital Intelligence Innovation, Leading Industrial Development”, focus on the digitalization of the pharmaceutical industry, and bring together government organization, Biotech and Biopharma, digital-intelligent transformation suppliers, investment institutions, and other industry stakeholders to discuss the trend and share successful experience of digital-intelligent transformation in pharmaceutical industry.
- Topics
- Take Advantage of National Policies to Develop Regional Ecology and Link Upstream and Downstream Industrial Channels
- Development Path and Reference Analysis of the Digital-Intelligent Transformation of Multinational Cooperation
- Analysis Current Situation and Development Trend of Digital-Intelligent Transformation in Domestic Pharmaceutical Industry
- All Stakeholders Discuss a Plan to Promote the Digital and Intelligent Development of the Pharmaceutical Industry
- Domestic Advanced Pharmaceutical Industry Shares Digital-Intelligent Transformation Experience.
- CONFERENCE HIGHLIGHT
Cohesion on Digital Intelligence Innovation Lead Industrial Development
Smart China Expo 2023 is supported by National Ministries and Commissions and Municipal Administration, focusing on the direction of “internationalization, specialization, and marketization“. As an important summit under the Smart China Expo——The Pharma Digital Intelligence Summit (PHDI 2023)combines the development frontier of global digital intelligence pharmaceuticals, focuses on the latest topics in the digital area,and gathers authoritative experts from domestic and abroad to analyze hot topics in digital pharmaceuticals.
Two Excellent Publishing Ceremony Explore Industrial Development Trend
The opening ceremony will lead the release of
Create a Brand Realizing and Benchmarking Annual Event
Lead the pharmaceutical industry policy and technology development trends, promote the integration of the pharmaceutical industry and the digital economy, and stimulate the leaping development of the pharmaceutical industry.
Build Digital Intelligence Exchange and Cooperation Platform for the Pharmaceutical Industry
Bring together government organization, Biotech and Biopharma, digital-intelligent transformation suppliers, investment institutions, and other supply chain experts, and empower the development of China's pharmaceutical industry through the joint support of policies, funds, and technologies.
*The agenda of the conference is for reference only and is subject to change on-site
Others
MoreNews 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.